George C. Shapiro
Tracked across 3 events · 19 articles · First seen Apr 09, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: George C. Shapiro, ZEO ScientifiX's Chief Medical Officer, serves as Chairman of the Medical Advisory Board. He emphasized the long-term goal of understanding and influencing biological systems that drive aging.
Jun 09, 2026 · 6 articles
Business
Impact: George C. Shapiro, Chief Medical Officer of ZEO ScientifiX, discussed the potential of the strategic collaboration to establish a scalable system for regenerative medicine.
Apr 09, 2026 · 7 articles
Business
ZEO ScientifiX, Inc. (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on regenerative biologics, announced on September 15, 2026 its planned expansion into Georgia and United States — Tennessee. The move follows the recent enactment of state…
Impact: Chief Medical Officer George C. Shapiro, MD, FACC, is quoted emphasizing education, documentation, and responsible clinical decision-making as ZEO ScientifiX enters the two new states.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track George C. Shapiro live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard